Chan Zeng

3.4k total citations · 1 hit paper
13 papers, 2.8k citations indexed

About

Chan Zeng is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Chan Zeng has authored 13 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Chan Zeng's work include Lung Cancer Treatments and Mutations (6 papers), HER2/EGFR in Cancer Research (5 papers) and Lung Cancer Research Studies (4 papers). Chan Zeng is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), HER2/EGFR in Cancer Research (5 papers) and Lung Cancer Research Studies (4 papers). Chan Zeng collaborates with scholars based in United States, Canada and Poland. Chan Zeng's co-authors include Wilbur A. Franklin, Paul A. Bunn, Anna E. Barón, Marileila Varella‐Garcia, Fred R. Hirsch, Robert Veve, Roy M. Bremnes, Michael V. Di Maria, Fred R. Hirsch and Daniel C. Chan and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Chan Zeng

13 papers receiving 2.7k citations

Hit Papers

Epidermal Growth Factor Receptor in Non–Small-Cell Lung C... 2003 2026 2010 2018 2003 250 500 750 1000

Peers

Chan Zeng
Shyhmin Huang United States
John C. Araujo United States
Marie Prewett United States
Victoria A. Joshi United States
Barbara A. Helfrich United States
Chan Zeng
Citations per year, relative to Chan Zeng Chan Zeng (= 1×) peers Ian Lorimer

Countries citing papers authored by Chan Zeng

Since Specialization
Citations

This map shows the geographic impact of Chan Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chan Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chan Zeng more than expected).

Fields of papers citing papers by Chan Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chan Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chan Zeng. The network helps show where Chan Zeng may publish in the future.

Co-authorship network of co-authors of Chan Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Chan Zeng. A scholar is included among the top collaborators of Chan Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chan Zeng. Chan Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Varella‐Garcia, Marileila, Tetsuya Mitsudomi, Yasushi Yatabe, et al.. (2009). EGFR and HER2 Genomic Gain in Recurrent Non-small Cell Lung Cancer After Surgery: Impact on Outcome to Treatment with Gefitinib and Association with EGFR and KRAS Mutations in a Japanese Cohort. Journal of Thoracic Oncology. 4(3). 318–325. 47 indexed citations
2.
Weiss, Glen J., Chan Zeng, Karen Kelly, Zung Vu Tran, & Paul A. Bunn. (2007). Single-Institution Experience with Pemetrexedand Bevacizumab as Salvage Therapy in AdvancedNon–Small-Cell Lung Cancer. Clinical Lung Cancer. 8(5). 335–338. 8 indexed citations
3.
Coldren, Christopher D., Barbara A. Helfrich, Samir E. Witta, et al.. (2006). Baseline Gene Expression Predicts Sensitivity to Gefitinib in Non–Small Cell Lung Cancer Cell Lines. Molecular Cancer Research. 4(8). 521–528. 107 indexed citations
5.
Franklin, Wilbur A., Chan Zeng, Holly J. Wolf, et al.. (2006). Chromosomal aneusomy in sputum predicts for lung cancer in nested case-control study. Journal of Clinical Oncology. 24(18_suppl). 7201–7201. 1 indexed citations
6.
Witta, Samir E., Robert M. Gemmill, Fred R. Hirsch, et al.. (2006). Restoring E-Cadherin Expression Increases Sensitivity to Epidermal Growth Factor Receptor Inhibitors in Lung Cancer Cell Lines. Cancer Research. 66(2). 944–950. 420 indexed citations
7.
Stearman, Robert S., Lori D. Dwyer‐Nield, Laura K. Zerbe, et al.. (2005). Analysis of Orthologous Gene Expression between Human Pulmonary Adenocarcinoma and a Carcinogen-Induced Murine Model. American Journal Of Pathology. 167(6). 1763–1775. 244 indexed citations
8.
Raben, David, B. Helfrich, Daniel C. Chan, et al.. (2005). The Effects of Cetuximab Alone and in Combination With Radiation and/or Chemotherapy in Lung Cancer. Clinical Cancer Research. 11(2). 795–805. 194 indexed citations
9.
Varella‐Garcia, Marileila, John Kittelson, Kieu O. Vu, et al.. (2004). Multi-target interphase fluorescence in situ hybridization assay increases sensitivity of sputum cytology as a predictor of lung cancer. Cancer Detection and Prevention. 28(4). 244–251. 59 indexed citations
10.
Соколова, И. А., Larry E. Morrison, Chan Zeng, et al.. (2003). Chromosomal Abnormalities in Non-Small Cell Lung Carcinomas and in Bronchial Epithelia of High-Risk Smokers Detected by Multi-Target Interphase Fluorescence in Situ Hybridization. Journal of Molecular Diagnostics. 5(2). 103–112. 58 indexed citations
11.
Hirsch, Fred R., Marileila Varella‐Garcia, Paul A. Bunn, et al.. (2003). Epidermal Growth Factor Receptor in Non–Small-Cell Lung Carcinomas: Correlation Between Gene Copy Number and Protein Expression and Impact on Prognosis. Journal of Clinical Oncology. 21(20). 3798–3807. 1166 indexed citations breakdown →
12.
Hirsch, Fred R., M. Varella-Garcia, Wilbur A. Franklin, et al.. (2002). Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas. British Journal of Cancer. 86(9). 1449–1456. 205 indexed citations
13.
Bunn, Paul A., B. Helfrich, Wilbur A. Franklin, et al.. (2001). Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents.. PubMed. 7(10). 3239–50. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026